Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q3 2022 Earnings Call Transcript November 8, 2022
Adaptimmune Therapeutics plc reports earnings inline with expectations. Reported EPS is $-0.24 EPS, expectations were $-0.24.
Operator: Hello and welcome to Adaptimmune’s Third Quarter Call and Business Update. I would now turn the call over to Juli Miller. Juli, please go ahead.
Juli Miller: Good morning and welcome to Adaptimmune’s conference call to discuss our third quarter 2022 financial results...
